Start Forschung Abteilungen / AGs / Institute Molekulares Neuroimaging Publikationen

Publikationen: Molekulares Neuroimaging

Gründer G, Mertens L. Psilocybin for Depression. N Engl J Med. 2021 385(9):863.
Krause-Utz A, Mertens L, Renn JB, Lucke P, Wöhlke AZ, van Schie CC, Mouthaan J. Childhood Maltreatment, Borderline Personality Features, and Coping as Predictors of Intimate Partner Violence. J Interpers Violence. 2021 36(13-14):6693-6721. Epub 2018 Dec 31..
Meinhardt M, Pfarr S, Fouquet G, Rohleder C, Meinhardt ML, Barroso-Flores J, Hoffmann R, Jeanblanc J, Paul E, Wagner K, Hansson AC, Köhr G, Meier N, von Bohlen und Halbach O, Bell RL, Endepols H, Neumaier B, Schönig K, Bartsch D, Naassila M, Spanagel R, Sommer WH. Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism. Sci Adv. 2021 7(47):eabh2399.
Schoretsanitis G, Haen E, Conca A, Piacentino D, Ridders F, Hiemke C, Gründer G, Paulzen M. Lack of Smoking Effects on Pharmacokinetics of Oral Paliperidone-analysis of a Naturalistic Therapeutic Drug Monitoring Sample. Pharmacopsychiatry. 2021 54(1):31-35. Epub 2020 Aug 6.
Schoretsanitis G, Haen E, Piacentino D, Conca A, Endres K, Carpi F, Hiemke C, Gründer G, Paulzen M. Pharmacokinetic Correlates of Once-Monthly Paliperidone Palmitate-Related Adverse Drug Reactions. Clin Pharmacokinet. 2021 Jun 18. [Epub ahead of print]


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de